Home » Topics » Regulatory

Regulatory
RSS

Activase cleared by FDA for ischemic stroke

June 14, 1996

Colchicine/hydroxychloroquine therapy of AD

June 14, 1996

Lithium/nimodipine combination as bipolar I manic disorder treatment

June 14, 1996

Xalatan approved for U.S. market

June 14, 1996

Actimmune metastatic renal cell carcinoma development terminated

June 14, 1996

Augmentin's new dosing/formulation cleared by FDA

June 14, 1996

Single-dose hepatitis A vaccine available

June 7, 1996

Tranilast: An angiotensin II antagonist

June 7, 1996

First chronotherapeutic agent for hypertension and angina now avaliable in U.S.

June 7, 1996

Elan acquires rights to diazepam gel formulation

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.